Using conditional deletion mouse models, this study evaluated the role of transcription factor BHLHE40 in group 3 innate lymphoid cells (ILC3s) and RORγt⁺ antigen-presenting cells (APCs) in regulating intestinal mucosal immunity and antigen-specific tolerance to commensal bacteria.
BHLHE40 drove cytokine effector programs in ILC3s (amplified by TL1A stimulation and inflammation via epigenetic chromatin remodeling) and was required in RORγt⁺ APCs for antigen-specific regulatory T cell (Treg) generation; it also promoted OX40L expression on ILC3s to further support Treg induction.
Findings are based on conditional deletion mouse models, limiting direct translation to human intestinal immunity; the specific downstream targets and mechanisms of BHLHE40-driven epigenetic modulation were not fully characterized; the study does not address therapeutic targeting strategies.
BHLHE40 is identified as a coordinated regulator of gut barrier immunity and tolerance — a potential future target in inflammatory bowel diseases — though clinical applications await human validation.
Explore related topics
